Kymera Therapeutics, Inc. - KYMR

About Gravity Analytica
Recent News
- 06.26.2025 - Wolfe Research Virtual Biotech Day
- 06.26.2025 - Wolfe Research Virtual Biotech Day
- 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
- 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
- 06.05.2025 - Jefferies Global Healthcare Conference
- 06.05.2025 - Jefferies Global Healthcare Conference
- 06.02.2025 - Kymera Therapeutics KT-621 Phase 1 Healthy Volunteer Results
- 06.02.2025 - Kymera Therapeutics KT-621 Phase 1 Healthy Volunteer Results
- 06.02.2025 - Kymera Therapeutics Announces Positive First-in-Human Results from Phase 1 Healthy Volunteer Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
- 06.02.2025 - Kymera Therapeutics Announces Positive First-in-Human Results from Phase 1 Healthy Volunteer Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader